Faculty Profile

Anjana Pillai
Section of Gastroenterology
Associate Professor of Medicine
Referring Physician Access Line: 1-877-DOM-2730

Academic Interests

Dr. Pillai’s research is focused on viral hepatitis and hepatocellular carcinoma.She is currently investigating the use of biomarkers to assess both disease response and progression.

Clinical Interests

Transplant hepatology and management of chronic liver diseases.


  • Pillai AA.Management of de novo malignancies after liver transplantation.Transplant Rev (Orlando). 2015 Jan;29(1):38-41.
  • Singal AG, Pillai A, Tiro J.Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.PLoS Med. 2014 Apr 1;11(4):e1001624.
  • Pillai AA, Anania FA, Pearlman BL.Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy.Am J Gastroenterol. 2016 Dec;111(12):1854-1856
  • Pillai AA, Wedd J, Norvell JP, Parekh S, Cheng N, Young N, Spivey JR, Ford R.Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience.Am J Gastroenterol. 2016 Feb;111(2):250-60.
  • Ahn J, Lim JK, Lee HM, Lok AS, Nguyen M, Pan CQ, Mannalithara A, Te H, Reddy KR, Trinh H, Chu D, Tran T, Lau D, Leduc TS, Min A, Trong Le L, Bae H, Van Tran S, Do S, Hann HW, Wong C, Han S, Pillai A, Park JS, Tong M, Scaglione S, Woog J, Kim WR.Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.Am J Gastroenterol. 2016 Sep;111(9):1297-304.
For a complete list of publications click here:


  • BS, 1998, University of Miami,
  • MD, 2002, University of Miami, Miller School of Medicine, Medicine
  • Residency, 2005, University of Illinois, Medicine
  • Fellowship, 2008, Cleveland Clinic, Gastroenterology
  • Fellowship, 2009, Northwestern Memorial Hospital, Transplant Hepatology